The group of SSc patients who were negative for ATA, ACA, and PM/Scl and had the highest surface expression of CD62L were not tested for other SSc-specific autoantibodies, such as anti-RNA polymerase, anti-fibrillarin, and anti-Th/To antibodies, so no conclusions can be drawn for this group. The gene discussed is ATM; the disease is systemic sclerosis.